Literature DB >> 33047938

Re: Uretero-inguinal hernia with obstructive urolithiasis.

Ahmed Khattak1, Oladapo Feyisetan1, Michael S Floyd1, Azizan Samsudin1.   

Abstract

Entities:  

Year:  2021        PMID: 33047938      PMCID: PMC7712706          DOI: 10.1590/S1677-5538.IBJU.2020.0570

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


× No keyword cloud information.
To the editor, We read with interest the recent radiology page publication by Rathburn et al. highlighting the case of a 64 year old male with prostate cancer who was incidentally found to have left hydronephrosis and renal impairment during staging. Formal computed tomography revealed a 1cm stone in his distal left ureter which was located within an inguinoscrotal hernia and his right distal ureter was also contained within the right inguinoscrotal hernia (1). The authors proceed to discuss the two variants of uretero-inguinal hernias and highlight the rarity of published cases illustrating obstructive uropathy as a consequence of ureters being located in inguinal herniae (2, 3). The subsequent surgical management is described with laparoscopic hernia repair followed by subsequent left ureteroscopy. Although the authors mention increased BMI as a risk factor for the development of ureteroinguinal hernia the BMI of the patient described is not mentioned and additionally it is not stated whether he had pyelograms intraoperatively or was stented post operatively. We have previously published a case of obstructive uropathy due to bilateral inguinoscrotal herniation in a 55 year old male with a BMI of 48 and renal dysfunction. Computed tomography revealed bilateral hydroureteronephrosis and tortuous ureters (4). Unlike the case illustrated by Rathbun et al. there was no history of prostate cancer or stone disease. We performed bilateral retrograde pyelography which revealed grossly elongated ureters which were contained with bilateral inguinal hernia. As he was a high operative risk we opted to manage him with long term stents. Due to his morbid obesity and tortuous ureters standard length stents were unable to reach his renal pelvis so we resorted to using 75 cm long ileal conduit stents which accommodated the uretero-inguinal hernia and facilitated the stents being passed into the renal pelvis (5). The authors are to be commended for describing a case of uretero-inguinal herniation with obstruction due to calculus disease. However, the authors should acknowledge that in the morbidly obese patient without stone disease ureterohydronephrosis may occur due to inguinal herniation in isolation without concomitant stone disease. These cases illustrate the challenges faced by endourologists when dealing with this rare entity. Yours Sincerely, The authors
  5 in total

1.  Inguinoscrotal hernias involving urologic organs: A case series.

Authors:  Jeffrey Peter McKay; Michael Organ; Scott Bagnell; Christopher Gallant; Christopher French
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

2.  Chronic obstructive uropathy due to uretero-inguinal hernia: A case report.

Authors:  Andy Chuk Moon Won; Gerard Testa
Journal:  Int J Surg Case Rep       Date:  2012-04-16

3.  Ureteral inguinal hernia: an uncommon trap for general surgeons.

Authors:  Zarif Yahya; Yahya Al-Habbal; Sayed Hassen
Journal:  BMJ Case Rep       Date:  2017-03-08

4.  Obstructive uropathy secondary to bilateral ureteroinguinoscrotal herniation.

Authors:  Oladapo Feyisetan; Michael S Floyd; Azi Samsudin
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

5.  Ureteroinguinal hernia with obstructive urolithiasis.

Authors:  JuliAnne R Rathbun; Nanda Thimmappa; Stephen H Weinstein; Katie S Murray
Journal:  Int Braz J Urol       Date:  2020 Sep-Oct       Impact factor: 3.050

  5 in total
  1 in total

1.  REPLY TO THE AUTHORS: Re: Ureteroinguinal hernia with obstructive urolithiasis.

Authors:  JuliAnne R Rathbun; Nanda Thimmappa; Stephen H Weinstein; Katie S Murray
Journal:  Int Braz J Urol       Date:  2021 Mar-Apr       Impact factor: 1.541

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.